[go: up one dir, main page]

GB8826371D0 - Antiviral compositions - Google Patents

Antiviral compositions

Info

Publication number
GB8826371D0
GB8826371D0 GB888826371A GB8826371A GB8826371D0 GB 8826371 D0 GB8826371 D0 GB 8826371D0 GB 888826371 A GB888826371 A GB 888826371A GB 8826371 A GB8826371 A GB 8826371A GB 8826371 D0 GB8826371 D0 GB 8826371D0
Authority
GB
United Kingdom
Prior art keywords
antiviral compositions
antiviral
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB888826371A
Other versions
GB2224649B (en
GB2224649A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ssali C L
Original Assignee
Ssali C L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssali C L filed Critical Ssali C L
Priority to GB8826371A priority Critical patent/GB2224649B/en
Publication of GB8826371D0 publication Critical patent/GB8826371D0/en
Publication of GB2224649A publication Critical patent/GB2224649A/en
Application granted granted Critical
Publication of GB2224649B publication Critical patent/GB2224649B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8826371A 1988-11-10 1988-11-10 Antiviral compositions comprising fusidic acid and l-ascorbic acid Expired - Lifetime GB2224649B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8826371A GB2224649B (en) 1988-11-10 1988-11-10 Antiviral compositions comprising fusidic acid and l-ascorbic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8826371A GB2224649B (en) 1988-11-10 1988-11-10 Antiviral compositions comprising fusidic acid and l-ascorbic acid

Publications (3)

Publication Number Publication Date
GB8826371D0 true GB8826371D0 (en) 1988-12-14
GB2224649A GB2224649A (en) 1990-05-16
GB2224649B GB2224649B (en) 1992-08-26

Family

ID=10646673

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8826371A Expired - Lifetime GB2224649B (en) 1988-11-10 1988-11-10 Antiviral compositions comprising fusidic acid and l-ascorbic acid

Country Status (1)

Country Link
GB (1) GB2224649B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116030D0 (en) * 1991-07-25 1991-09-11 Ssali Charles L Antiviral compositions
US20100120896A1 (en) * 2008-07-08 2010-05-13 Sanna Sander Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus
CN106749475B (en) * 2017-01-13 2018-11-23 广东工业大学 A kind of preparation and purposes of Fusidic Acid chemical modification object

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249632A4 (en) * 1985-12-05 1988-06-20 American Biotechnology Anthracycline type antitumor agents with l-ascorbic acid.

Also Published As

Publication number Publication date
GB2224649B (en) 1992-08-26
GB2224649A (en) 1990-05-16

Similar Documents

Publication Publication Date Title
GB8808305D0 (en) Compositions
NZ222695A (en) Synergistic antiviral compositions
PH27609A (en) Antiviral agents
ZA901993B (en) Antiviral compositions
GB8804457D0 (en) Compositions
GB8815593D0 (en) Compositions
HUT49983A (en) Antifungoid compositions
GB8813144D0 (en) Compositions
GB8811616D0 (en) Compositions
GB8829571D0 (en) Antiviral compounds
GB8911158D0 (en) Antiviral pyridazinamines
EP0450065A4 (en) Antiviral agent
GB9116030D0 (en) Antiviral compositions
GB8826371D0 (en) Antiviral compositions
GB2207864B (en) Antiviral composition comprising isopropyldeoxyuridine
EP0440710A4 (en) New antiviral agents
GB8902908D0 (en) Non-veterinary composition(c)
GB8829443D0 (en) Compositions
IE880742L (en) Antiviral compositions
IE881995L (en) Antiviral compositions
GB8810602D0 (en) Compositions
IE882087L (en) Anti-anxiogenic dioxopiperidine compositions
GB8828707D0 (en) Compositions
GB8826479D0 (en) Compositions
GB8801095D0 (en) Compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19961110